Earnings
SYRS
4.880
+2.31%
0.110
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
173.98M
0.00
--
2.33M
--
--
0.00
--
--
--
2.24M
--
178.56M
29.64M
--
--
--
--
--
--
5.05M
34.69M
213.25M
--
3.60M
0.00
--
--
--
--
--
12.55M
--
--
--
12.21M
28.62M
39.91M
--
--
--
54.17M
94.07M
122.70M
56.00K
467.52M
-377.02M
--
--
--
90.55M
90.55M
213.25M
FY 2019-12-31
41.44M
49.98M
--
20.16M
--
--
0.00
--
--
--
2.65M
290.00K
114.51M
31.89M
--
--
--
--
--
--
3.58M
35.47M
149.98M
--
5.85M
0.00
--
--
--
--
--
11.68M
--
--
--
5.74M
23.52M
621.00K
--
--
--
46.66M
47.28M
70.79M
43.00K
372.10M
-292.98M
--
--
--
79.18M
79.18M
149.98M
FY 2018-12-31
49.89M
49.79M
--
--
--
--
0.00
--
--
--
1.42M
638.00K
101.73M
3.86M
--
--
--
--
--
--
1.17M
5.03M
106.77M
--
3.31M
0.00
--
--
--
--
--
13.89M
--
--
--
2.32M
19.53M
22.00K
--
--
--
8.63M
8.65M
28.18M
34.00K
296.10M
-217.54M
--
--
--
78.59M
78.59M
106.77M
FY 2017-12-31
32.20M
39.84M
--
0.00
--
--
0.00
--
--
--
917.00K
193.00K
73.16M
3.94M
--
--
--
--
--
--
1.39M
5.33M
78.49M
--
2.28M
0.00
--
--
--
--
--
9.73M
--
--
--
355.00K
12.41M
6000.00
--
--
--
745.00K
751.00K
13.16M
26.00K
220.61M
-155.27M
--
--
--
65.32M
65.32M
78.49M
FY 2016-12-31
58.59M
25.00M
--
867.00K
--
--
0.00
--
--
--
1.05M
--
85.51M
4.85M
--
--
--
--
--
--
965.00K
5.82M
91.32M
--
2.42M
0.00
--
--
--
--
--
6.12M
--
--
--
869.00K
9.57M
53.00K
--
--
--
1.10M
1.15M
10.72M
23.00K
181.84M
-101.26M
--
--
--
80.60M
80.60M
91.32M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out SYRS latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Syros Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.